Log in to your Inderes Free account to see all free content on this page.

Carbiotix

Be the first to follow this company

Carbiotix is a biotechnology company active in the microbiome area. The company currently conducts research and development and sells products and services in primarily four business areas: Diagnosis of intestinal health, prebiotic ingredients, medical food and therapeutic treatments. The company was founded in 2014 and is headquartered in Lund.

ShowingAll content types

Regulatory press release12/20/2024, 7:55 AM

Carbiotix provides Q4 2024 update of ongoing NutraCycle projects

Press release9/30/2024, 1:15 PM

Carbiotix provides Q3 2024 update of ongoing NutraCycle projects

Regulatory press release8/29/2024, 8:15 PM

Carbiotix initiates eight new NutraCycle pre-study projects and will begin quarterly reporting of new and ongoing customer projects

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Press release8/23/2024, 6:45 AM

Carbiotix completes metformin study and provides EU funding update

Regulatory press release7/8/2024, 8:30 AM

The Board of Directors of Carbiotix AB (publ) proposes a directed share issue of a maximum of approximately SEK 7.00 million

Press release6/28/2024, 6:45 AM

Carbiotix AB's warrant exercise registered at the Swedish Companies Registration Office

Press release6/20/2024, 6:00 PM

Carbiotix AB announces the outcome of the exercise of warrants of series TO 3

Press release6/17/2024, 12:30 PM

Carbiotix provides update of staff re-organisation

Press release6/13/2024, 6:45 AM

Carbiotix: The last day of trading in warrants of series TO 3 is on the 17th of June 2024

Press release6/5/2024, 6:30 AM

Carbiotix: The exercise period for warrants of series TO 3 commences today

Press release6/3/2024, 5:00 PM

Carbiotix: The exercise price for warrants of series TO 3 has been set to SEK 0.04 per new share

Regulatory press release5/28/2024, 9:30 AM

Carbiotix announces strategic re-focus and staff re-organisation

Regulatory press release4/25/2024, 8:30 AM

Carbiotix signs first NutraCycle Joint Development Agreement with leading Nordic plant-based food & beverage producer

Regulatory press release4/4/2024, 9:00 AM

Carbiotix commences NutraCycle pilot study with leading US food & beverage producer

Press release3/20/2024, 11:05 AM

Carbiotix rebrands prebiotic ingredient CarbiAXOS to Carbersol

Press release3/19/2024, 12:00 PM

Carbiotix announces European and US tradeshow schedule for 2024

Press release3/13/2024, 11:00 AM

Carbiotix ramps up prebiotic and technology partner evaluation activities

Regulatory press release3/12/2024, 3:00 PM

Carbiotix receives first animal related LinkGut service order

Regulatory press release3/6/2024, 3:15 PM

Carbiotix commences NutraCycle pre-study with leading US food & beverage producer

Regulatory press release3/5/2024, 2:15 PM

Carbiotix launches NutraCycle - a new upcycling service for food & beverage producers

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.